Elif Atağ Akyürek

7PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Optical technologyPredictive and prognostic markersWomen's studies (incl. girls' studies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG).

Sercan On, Selin Cebeci, Zeynep Hande Turna

|Sep 29, 2023
Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer.

Ridvan Kayar, Yavuz Bastug, Emre Tokuc

|Aug 06, 2023
Syrian Refugee and Turkish Women with Breast Cancer: A Comparison on Clinicopathological Features and Survival.

Elif Atag, Serkan Gokcay, Eda Tanrikulu Simsek

|Aug 29, 2022
CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.

Hüseyin S Semiz, Ülkü Küçük, Erdem Kısa

|Aug 11, 2020
Factors influencing physical activity in patients with colorectal cancer.

Dilek Kucukvardar, Didem Karadibak, Ismail Ozsoy

Pageof 2

Frequent Collaborators

2 joint publications

Hüseyin Salih Semiz

2 joint publications

Murat Sarı

1 joint publications

Pinar Soysal

1 joint publications

Ülkü Küçük